Abstract
Optimizing quality of life is a major goal for patients with unresectable pancreatic cancer and distal cholangiocarcinoma. The aim of this study was to assess the value of robotic surgery for palliation in these patients. Between May 2007 and January 2010, nine patients who presented with unresectable pancreatic cancer or distal cholangiocarcinoma at exploratory laparoscopy were included in this retrospective study. Eight hepaticojejunostomies, one choledochoduodenostomy and five gastrojejunostomies were performed robotically. Mean operative time was 236 ± 25 min. Median length of stay was 6 (range 4-10) days. There was no perioperative mortality. The morbidity rate was 22.2%. After a median follow-up of 265 days, there were no other readmissions for problems related to the operation. Robotic palliation in cases of unresectable pancreatic cancer or distal cholangiocarcinoma is feasible and effective. The use of robotics in palliative surgery offers low morbidity, short hospital stay and minimal readmissions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The International Journal of Medical Robotics and Computer Assisted Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
